Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | -2.72% | +5.92% | +78.16% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
EBIT
- Stock Market
- Equities
- SMMT Stock
- Revisions Summit Therapeutics Inc.